搜尋結果
醫學主題詞表（MeSH）：Tacrolimus FDA Approves New Use of Transplant Drug Based on Real-World Evidence . U.S. Food and Drug Administration (FDA). 30 September 2021 [ 2022-12-18 ] .
如何在香港購買他克莫司(Tacrolimus)? 在香港，他克莫司是一種處方藥物，需要醫生處方才能在藥房購買。 你也可以從醫生那裡獲得。
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogenic organ transplant , the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given.
此為免疫抑制劑，藉抑制淋巴球受體活化，進而阻斷免疫系統的過度免疫反應。. 用法與用量. 1.移植：一般起始劑量為0.01~0.05mg/kg，在手術完成後6小時開始給藥。. 之後的口服維持劑量一般每天一到兩次，依指示使用，建議空腹服用。. 2.異位性皮膚炎：在患部 ...
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. The American Journal of Gastroenterology. May 2006, 101 (5): 1048–56.
通常移植前2天，口服 tacrolimus一天兩次，一次0.15mg/kg。手術後初期，口服 tacrolimus 一天兩次，一次0.15mg/kg。然後逐漸減量至維持劑量一次 0.06mg/kg，一天兩次為標準，但可依病患症狀適當地調整。肝臟移植通常初期口服
2015年12月31日 · Tacrolimus acts by reducing peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP-12 (FK506 binding protein) creating a new complex. This inhibits both T-lymphocyte signal transduction and IL-2 transcription. Tacrolimus has similar activity to
Tacrolimus: Belongs to the class of calcineurin inhibitors. Used as immunosuppressants. Our drug directory offers in-depth details on its uses, side effects, and more.
Tacrolimus-Teva(tacrolimus): Prevents rejection of the transplanted organ. May be given for an ongoing rejection of transplanted liver, kidney, heart or ot education |
Tacrolimus(FK506, Prograf)是一種免疫抑制藥物，用於預防及治療器官移植後之排斥作用。 Tacrolimus會和細胞內的FK-binding protein 結合，抑制calcineurin的磷酸?的功能，使得T 淋巴球受體活化後訊號傳遞路徑受阻，抑制G0往G1，進而抑制細胞激素interleukin-2的分泌。
